Evidence map›Paper›PMID 35491256›Full record

ReviewTrends in neurosciences2022

Nonapoptotic caspases in neural development and in anesthesia-induced neurotoxicity.

Nemanja Sarić, Kazue Hashimoto-Torii, Vesna Jevtović-Todorović, Nobuyuki Ishibashi

Open access · greenAbstract readReview
In one paragraph

Review in Trends in neurosciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 17 citations in OpenAlex.

  1. Neurogranin Promotes Neuronal Maturation and Network Activity Through CaInternational journal of molecular sciences · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Autism risk geneFrontiers in cellular neuroscience · 2024
    Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 1 country.

Nemanja SarićCenter for Neuroscience Research, Children's National Hospital, Washington, DC, USA.
Kazue Hashimoto-ToriiCenter for Neuroscience Research, Children's National Hospital, Washington, DC, USA; Department of Pediatrics, Pharmacology and Physiology, George Washington University School of Medicine and Health Sciences, Washington, DC, USA.
Vesna Jevtović-TodorovićDepartment of Anesthesiology, University of Colorado School of Medicine, Aurora, CO, USA.
Nobuyuki IshibashiCenter for Neuroscience Research, Children's National Hospital, Washington, DC, USA; Department of Pediatrics, Pharmacology and Physiology, George Washington University School of Medicine and Health Sciences, Washington, DC, USA; Children's National Heart Institute, Children's National Hospital, Washington, DC, USA. Electronic address: nishibas@childrensnational.org.
Children's National · USGeorge Washington University Hospital · USJefferson Hospital for Neuroscience · USUniversity of Colorado Denver · US

Funding

Neurobehavioral Evaluation CoreP50HD105328 · NICHD · CHILDREN'S RESEARCH INSTITUTE · PI WILLIAM Davis GAILLARD · 2021 to 2026
$9.3M
Cell Therapy for Neuroprotection in Congenital Heart DiseaseR01HL139712 · NHLBI · CHILDREN'S RESEARCH INSTITUTE · PI Nobuyuki Ishibashi · 2018 to 2026
$5.7M
White Matter Protection in the Fetus with Congenital Heart DiseaseR01HL146670 · NHLBI · CHILDREN'S RESEARCH INSTITUTE · PI ISHIBASHI, NOBUYUKI · 2020 to 2023
$3.3M
Novel neurosteroid anesthetics and developmental synaptogenesisR01HD097990 · NICHD · UNIVERSITY OF COLORADO DENVER · PI JEVTOVIC-TODOROVIC, VESNA · 2019 to 2023
$2.9M
Mesenchymal Stromal Cell Delivery through Cardiopulmonary Bypass in Pediatric Cardiac SurgeryR33HL146394 · NHLBI · CHILDREN'S RESEARCH INSTITUTE · PI BOLLARD, CATHERINE M., ISHIBASHI, NOBUYUKI · 2019 to 2021
$2.6M
NHLBI NIH HHS R01 HL139712NHLBI NIH HHS R01 HL146670NHLBI NIH HHS R33 HL146394NICHD NIH HHS P50 HD105328NICHD NIH HHS R01 HD097990
6 · The paper itself

Abstract

Apoptosis, classically initiated by caspase pathway activation, plays a prominent role during normal brain development as well as in neurodegeneration. The noncanonical, nonlethal arm of the caspase pathway is evolutionarily conserved and has also been implicated in both processes, yet is relatively understudied. Dysregulated pathway activation during critical periods of neurodevelopment due to environmental neurotoxins or exposure to compounds such as anesthetics can have detrimental consequences for brain maturation and long-term effects on behavior. In this review, we discuss key molecular characteristics and roles of the noncanonical caspase pathway and how its dysregulation may adversely affect brain development. We highlight both genetic and environmental factors that regulate apoptotic and sublethal caspase responses and discuss potential interventions that target the noncanonical caspase pathway for developmental brain injuries.

Indexed as

AnesthesiaCaspasesApoptosisBrainCaspase 3HumansNeurogenesisCaspase 3Caspasesanesthesianeurodegenerationneurodevelopmentnonlethal caspase

Identifiers

PMID35491256
PMCPMC9117442
OpenAlexW4225324895

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.